ImageneBio, Inc. GAAP EPS of -$0.63 (IMA:NASDAQ)
· seekingalpha.com
ImageneBio (IMA) Q2 earnings: GAAP EPS -$0.63, $136.2M cash after $30M PIPE, runway into Q1 2028; R&D/G&A trends—read the key takeaways.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...